202 related articles for article (PubMed ID: 37148296)
61. Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer.
Boeke S; Thorwarth D; Mönnich D; Pfannenberg C; Reischl G; La Fougère C; Nikolaou K; Mauz PS; Paulsen F; Zips D; Welz S
Acta Oncol; 2017 Nov; 56(11):1571-1576. PubMed ID: 28891398
[TBL] [Abstract][Full Text] [Related]
62. Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.
Wang W; Lee NY; Georgi JC; Narayanan M; Guillem J; Schöder H; Humm JL
J Nucl Med; 2010 Jan; 51(1):37-45. PubMed ID: 20008982
[TBL] [Abstract][Full Text] [Related]
63. FMISO as a Biomarker for Clinical Radiation Oncology.
Zschaeck S; Steinbach J; Troost EG
Recent Results Cancer Res; 2016; 198():189-201. PubMed ID: 27318688
[TBL] [Abstract][Full Text] [Related]
64. Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors.
Nishikawa Y; Yasuda K; Okamoto S; Ito YM; Onimaru R; Shiga T; Tsuchiya K; Watanabe S; Takeuchi W; Kuge Y; Peng H; Tamaki N; Shirato H
Radiat Oncol; 2017 Sep; 12(1):148. PubMed ID: 28877734
[TBL] [Abstract][Full Text] [Related]
65. Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance.
Hendrickson K; Phillips M; Smith W; Peterson L; Krohn K; Rajendran J
Radiother Oncol; 2011 Dec; 101(3):369-75. PubMed ID: 21872957
[TBL] [Abstract][Full Text] [Related]
66. Improving Tumor Hypoxia Location in
Gertsenshteyn I; Epel B; Barth E; Leoni L; Markiewicz E; Tsai HM; Fan X; Giurcanu M; Bodero D; Zamora M; Sundramoorthy S; Kim H; Freifelder R; Bhuiyan M; Kucharski A; Karczmar G; Kao CM; Halpern H; Chen CT
Radiol Imaging Cancer; 2021 Mar; 3(2):e200104. PubMed ID: 33817651
[TBL] [Abstract][Full Text] [Related]
67. Hypoxia imaging with [18F]-FMISO-PET for guided dose escalation with intensity-modulated radiotherapy in head-and-neck cancers.
Henriques de Figueiredo B; Zacharatou C; Galland-Girodet S; Benech J; De Clermont-Gallerande H; Lamare F; Hatt M; Digue L; De Mones del Pujol E; Fernandez P
Strahlenther Onkol; 2015 Mar; 191(3):217-24. PubMed ID: 25245468
[TBL] [Abstract][Full Text] [Related]
68. Application of integrated positron emission tomography/magnetic resonance imaging in evaluating the prognostic factors of head and neck squamous cell carcinoma with positron emission tomography, diffusion-weighted imaging, dynamic contrast enhancement and combined model.
Dang H; Chen Y; Zhang Z; Shi X; Chen X; Zhu X; Hou B; Xing H; Xue H; Jin Z
Dentomaxillofac Radiol; 2020 Jul; 49(5):20190488. PubMed ID: 32202922
[TBL] [Abstract][Full Text] [Related]
69. Comparison of (immuno-)fluorescence data with serial [¹⁸F]Fmiso PET/CT imaging for assessment of chronic and acute hypoxia in head and neck cancers.
Maftei CA; Shi K; Bayer C; Astner ST; Vaupel P
Radiother Oncol; 2011 Jun; 99(3):412-7. PubMed ID: 21719136
[TBL] [Abstract][Full Text] [Related]
70. Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.
Lee N; Nehmeh S; Schöder H; Fury M; Chan K; Ling CC; Humm J
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):101-8. PubMed ID: 19203843
[TBL] [Abstract][Full Text] [Related]
71. Correlation between 18F-FDG PET/CT and diffusion-weighted MRI parameters in head and neck squamous cell carcinoma at baseline and after chemo-radiotherapy. A retrospective single institutional study.
Garau LM; Manca G; Bola S; Aringhieri G; Faggioni L; Volterrani D
Oral Radiol; 2022 Apr; 38(2):199-209. PubMed ID: 34133000
[TBL] [Abstract][Full Text] [Related]
72. Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer.
Skipar K; Hompland T; Lund KV; Løndalen A; Malinen E; Kristensen GB; Lindemann K; Nakken ES; Bruheim K; Lyng H
Radiother Oncol; 2022 Nov; 176():17-24. PubMed ID: 36113778
[TBL] [Abstract][Full Text] [Related]
73. Diffusion-weighted MRI and
Chung YH; Yu CF; Chiu SC; Chiu H; Hsu ST; Wu CR; Yang CL; Hong JH; Yen TC; Chen FH
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1733-1744. PubMed ID: 31127350
[TBL] [Abstract][Full Text] [Related]
74. Brain hypoxia mapping in acute stroke: Back-to-back T2' MR versus
Jensen-Kondering U; Manavaki R; Ejaz S; Sawiak SJ; Carpenter TA; Fryer TD; Aigbirhio FI; Williamson DJ; Baron JC
Int J Stroke; 2017 Oct; 12(7):752-760. PubMed ID: 28523963
[TBL] [Abstract][Full Text] [Related]
75. Comparison of Hypermetabolic and Hypoxic Volumes Delineated on [
Thureau S; Modzelewski R; Bohn P; Hapdey S; Gouel P; Dubray B; Vera P
Mol Imaging Biol; 2020 Jun; 22(3):764-771. PubMed ID: 31432388
[TBL] [Abstract][Full Text] [Related]
76. Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging.
Carmona-Bozo JC; Manavaki R; Woitek R; Torheim T; Baxter GC; Caracò C; Provenzano E; Graves MJ; Fryer TD; Patterson AJ; Gilbert FJ
Eur Radiol; 2021 Jan; 31(1):333-344. PubMed ID: 32725330
[TBL] [Abstract][Full Text] [Related]
77. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02.
Rischin D; Hicks RJ; Fisher R; Binns D; Corry J; Porceddu S; Peters LJ;
J Clin Oncol; 2006 May; 24(13):2098-104. PubMed ID: 16648512
[TBL] [Abstract][Full Text] [Related]
78. Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study.
Sun H; Xin J; Zhang S; Guo Q; Lu Y; Zhai W; Zhao L; Peng W; Wang B
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):898-905. PubMed ID: 24463908
[TBL] [Abstract][Full Text] [Related]
79. Geometrical Comparison and Quantitative Evaluation of
Li H; Li J; Li F; Zhang Y; Li Y; Guo Y; Xu L
Front Oncol; 2021; 11():772428. PubMed ID: 35004291
[TBL] [Abstract][Full Text] [Related]
80. Multiparametric functional MRI and
Martens RM; Koopman T; Lavini C; Ali M; Peeters CFW; Noij DP; Zwezerijnen G; Marcus JT; Vergeer MR; Leemans CR; de Bree R; de Graaf P; Boellaard R; Castelijns JA
Eur Radiol; 2021 Feb; 31(2):616-628. PubMed ID: 32851444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
